Skip to content

EXOZ EXOZ Deferred income

Deferred income at other companies

MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$64.84M+8.8%
Jerash Holdings (US), Inc. logo
Jerash Holdings (US), Inc.JRSH
$120
Arteris, Inc. logo
Arteris, Inc.AIP
$6.16M-16.1%
Intrepid Potash logo
Intrepid PotashIPI
$42.67M-5.0%
XOMA Corporation logo
XOMA CorporationXOMA
$2.86M-30.0%
MP Materials logo
MP MaterialsMP
$24.52M+11.3%

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeNoncurrent.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's deferred income?
EXOZ (EXOZ) reported deferred income of $78.37K in Q1 2026.
How has EXOZ's deferred income changed year-over-year?
EXOZ's deferred income decreased by 28.8% year-over-year, from $110.12K to $78.37K.
What is the long-term trend for EXOZ's deferred income?
Over 2 years (2023 to 2025), EXOZ's deferred income has grown at a -19.9% compound annual growth rate (CAGR), from $140.7K to $90.37K.
What does deferred income mean?
This reflects payments received from customers or partners for goods or services that have not yet been delivered or earned over a long-term period. It indicates future revenue visibility and the company's ability to secure upfront funding for long-term biomanufacturing projects.